scholarly article | Q13442814 |
P2093 | author name string | K M Fox | |
SHIELD Study Group | |||
S Grandy | |||
D D Bazata | |||
P2860 | cites work | The relationship of body mass index to diabetes mellitus, hypertension and dyslipidaemia: comparison of data from two national surveys | Q31112204 |
Prevalence of self-reported diagnosis of diabetes mellitus and associated risk factors in a national survey in the US population: SHIELD (Study to Help Improve Early evaluation and management of risk factors Leading to Diabetes). | Q33301484 | ||
Obesity and diabetes in the developing world--a growing challenge | Q34603178 | ||
Health-related quality of life following a clinical weight loss intervention among overweight and obese adults: intervention and 24 month follow-up effects | Q35005527 | ||
Type 2 diabetes: where we are today: an overview of disease burden, current treatments, and treatment strategies | Q37607893 | ||
Validity of self-reported height and weight in 4808 EPIC-Oxford participants | Q47179229 | ||
A prospective study of weight change and health-related quality of life in women | Q47251682 | ||
Changes in body weight and health-related quality-of-life in the older adult population | Q47371840 | ||
P433 | issue | 5 | |
P921 | main subject | type 2 diabetes | Q3025883 |
quality of life | Q13100823 | ||
P304 | page(s) | 455-461 | |
P577 | publication date | 2013-05-01 | |
P1433 | published in | International Journal of Clinical Practice | Q15758177 |
P1476 | title | Health-related quality of life association with weight change in type 2 diabetes mellitus: perception vs. reality | |
P478 | volume | 67 |
Q33720446 | Advances in managing type 2 diabetes: challenging old paradigms and developing new ones |
Q47187857 | Changes in weight loss-related quality of life among type 2 diabetes mellitus patients treated with dapagliflozin |
Q37257372 | Effectiveness and safety of glimepiride and iDPP4, associated with metformin in second line pharmacotherapy of type 2 diabetes mellitus: systematic review and meta-analysis. |
Q41570665 | Estimating Cost-Effectiveness in Type 2 Diabetes: The Impact of Treatment Guidelines and Therapy Duration |
Q47920825 | Patient-reported outcomes among patients with type 2 diabetes mellitus treated with dapagliflozin in a triple-therapy regimen for 52 weeks |
Q36073914 | Relationship between self-reported weight change, educational status, and health-related quality of life in patients with diabetes in Luxembourg |
Search more.